Predictive value of tumor mutational burden for PD-1/PD-L1 inhibitors in NSCLC: A meta-analysis

BACKGROUND: To investigate the association between tumor mutational burden (TMB) and the therapeutic effect of Programmed Death 1/Programmed Death Ligand 1 inhibitors in non-small cell lung cancer. METHODS: Four electronic databases, PubMed, Embase, Web of Science, and Cochrane Library, were searche...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wenjie, Zhao, Yanjun, Zhang, Hongjun, Zheng, Wenying, Wang, Ruixuan, Gu, Xing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
6700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553067/
https://www.ncbi.nlm.nih.gov/pubmed/37800825
http://dx.doi.org/10.1097/MD.0000000000034990

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553067/
https://www.ncbi.nlm.nih.gov/pubmed/37800825
http://dx.doi.org/10.1097/MD.0000000000034990

Ejemplares similares